Monash academics achieve international recognition as “highly cited” researchers
Monash University researchers have had significant success in the 2015 list of Highly Cited (HiCi) researchers, released today by Thomson Reuters, with 11 Monash academics included on the list. The HiCi list recognises the top one per cent of most highly cited researchers in the world within a subject area. Of the 11 researchers, 6 are in the area of Pharmacology and Toxicology, and this places Monash with the highest number of highly cited researchers in this field in the world.
According to Monash University Provost, Professor Edwina Cornish: “Our success in the HiCi list reflects the University’s focus on and investment in high quality impactful research and places our researchers among the very best in their field. Our academic staff are to be congratulated on their significant achievement, which recognises their influential research and their scientific contributions internationally”.
Professor Bill Charman, Dean, Faculty of Pharmacy and Pharmaceutical Sciences and Director, Monash Institute of Pharmaceutical Sciences (MIPS), has an impressive record of research achievements in the fields of drug discovery, delivery and new medicine development.
Working with his team at MIPS, Professor Chris Porter is addressing the poor oral absorption of new drug candidates, and to develop delivery systems to enhance the activity and reduce toxicity of existing medicines and new drug candidates.
Internationally acknowledged pharmacologist, Professor Arthur Christopoulos for MIPS is working to end the reign of "blunt hammer" medicines. By targeting previously unappreciated drug recognition sites in the body, he and his colleagues are developing medicines potent enough to offer better treatment of schizophrenia and diabetes, and selective enough to eliminate side-effects. This is the second time he has achieved highly cited status.
Molecular and stem cell biologist at MIPS, Professor Colin Pouton, is undertaking research in drug discovery and drug delivery and has a particular interest in neurological and neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease.
Professor Roger Nation, Professor Jian Li, and their teams of researchers at MIPS are researching solutions to the increasing problem of multidrug-resistant, "superbug" bacteria. Their research into the polymyxin group of antibiotics is already guiding doctors on new antibiotic dosage regimens for critically ill patients.
With an international reputation in the area of crystal engineering, Professor Stuart Batten from the School of Chemistry is a world leading expert on the phenomenon of interpenetration of networks in crystal structures. This is the second time he has achieved highly cited status.
Professor Dan Li from the Department of Materials Science and Engineering, is a second time highly cited researcher. His research focuses on discovering an efficient way to produce large amounts of graphene - a carbon-based material with extraordinary electrical, optical, thermal and mechanical properties, to process and assemble it into useful macrostructures.
The late Professor Henry Krum from the School of Public Health and Preventive Medicine accomplished outstanding achievements in the field of cardiovascular disease. He was a member of the Executive Committee that established the value of beta-blockers in severe heart failure.
Professor Rinaldo Bellomo from the Faculty of Medicine is a second time highly cited researcher. In 2004, he was named one of the world's most influential scientific minds of our time by Thomson Reuters. A recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award, his expertise spans traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics.
Director of Brain and Mental Health Laboratory in the School of Psychological Sciences, Professor Murat Yücel, is an expert in the area of biological psychiatry and addiction neuroscience. His work in the application of psychological and brain imaging techniques to human populations has led to increased public and professional awareness across addiction and psychiatric neuroscience research in Australia.
HiCi performance is a key indicator used to rank the top research universities in the Academic Ranking of World Universities, issued by Shanghai Jiao Tong University.